CoChat

Identification of Celecoxib-Targeted Proteins Using Label-Free Thermal Proteome Profiling on Rat Hippocampus

Gholizadeh, Elham, Karbalaei, Reza, Khaleghian, Ali, Salimi, Mona, Gilany, Kambiz, Soliymani, Rabah, Tanoli, Ziaurrehman, Rezadoost, Hassan, Baumann, Marc, Jafari, Mohieddin, Tang, Jing · 2021 · Molecular Pharmacology
Cited by 18

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1124/molpharm.120.000210

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 90

  1. Acharya, 2012, Neuronal PAD4 expression and protein citrullination: possible role in production of autoantibodies associated with neurodegenerative disease, J Autoimmun, 38, 369, 10.1016/j.jaut.2012.03.004 · DOI
  2. Agius, 2012, Neuroinflammation as the proximate cause of signature pathogenic pattern progression in amyotrophic lateral sclerosis, AIDS, and multiple sclerosis, Pathol Res Int, 2012, 10.1155/2012/169270 · DOI
  3. Akiyama, 2000, Inflammation and Alzheimer’s disease, Neurobiol Aging, 21, 383, 10.1016/S0197-4580(00)00124-X · DOI · Paper page
  4. Asial, 2013, Engineering protein thermostability using a generic activity-independent biophysical screen inside the cell, Nat Commun, 4, 2901, 10.1038/ncomms3901 · DOI
  5. Assefnia, 2014, Cadherin-11 in poor prognosis malignancies and rheumatoid arthritis: common target, common therapies, Oncotarget, 5, 1458, 10.18632/oncotarget.1538 · DOI
  6. Atukorala, 2013, Valdecoxib: the rise and fall of a COX-2 inhibitor, Expert Opin Pharmacother, 14, 1077, 10.1517/14656566.2013.783568 · DOI
  7. Bento, 2014, The ChEMBL bioactivity database: an update, Nucleic Acids Res, 42, D1083, 10.1093/nar/gkt1031 · DOI · Paper page
  8. Chen, 2013, Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool, BMC Bioinformatics, 14, 128, 10.1186/1471-2105-14-128 · DOI · Paper page
  9. Chia, 2009, Emerging roles for Rab family GTPases in human cancer, Biochim Biophys Acta, 1795, 110
  10. Chuang, 2008, COX-2 inhibition is neither necessary nor sufficient for celecoxib to suppress tumor cell proliferation and focus formation in vitro, Mol Cancer, 7, 38, 10.1186/1476-4598-7-38 · DOI
  11. Dannenberg, 2003, Targeting cyclooxygenase-2 in human neoplasia: rationale and promise, Cancer Cell, 4, 431, 10.1016/S1535-6108(03)00310-6 · DOI · Paper page
  12. Dembo, 2005, Central nervous system concentrations of cyclooxygenase-2 inhibitors in humans, Anesthesiology, 102, 409, 10.1097/00000542-200502000-00026 · DOI · Paper page
  13. Eikelenboom, 2004, Neuroinflammatory perspectives on the two faces of Alzheimer’s disease, J Neural Transm (Vienna), 111, 281, 10.1007/s00702-003-0055-1 · DOI · Paper page
  14. Eppig, 2017, Mouse Genome Informatics (MGI): resources for mining mouse genetic, genomic, and biological data in support of primary and translational research, Methods Mol Biol, 1488, 47, 10.1007/978-1-4939-6427-7_3 · DOI
  15. Fond, 2014, Effectiveness and tolerance of anti-inflammatory drugs’ add-on therapy in major mental disorders: a systematic qualitative review, Acta Psychiatr Scand, 129, 163, 10.1111/acps.12211 · DOI · Paper page
  16. Franken, 2015, Thermal proteome profiling for unbiased identification of direct and indirect drug targets using multiplexed quantitative mass spectrometry, Nat Protoc, 10, 1567, 10.1038/nprot.2015.101 · DOI · Paper page
  17. Gagliano Taliun, 2020, Exploring and visualizing large-scale genetic associations by using PheWeb, Nat Genet, 52, 550, 10.1038/s41588-020-0622-5 · DOI · Paper page
  18. Gaudet, 2011, Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium, Brief Bioinform, 12, 449, 10.1093/bib/bbr042 · DOI · Paper page
  19. Gilliam, 2013, Evaluation of anti-citrullinated type II collagen and anti-citrullinated vimentin antibodies in patients with juvenile idiopathic arthritis, Pediatr Rheumatol Online J, 11, 31, 10.1186/1546-0096-11-31 · doi:10.1186/1546-0096-11-31
  20. Goldstein, 2009, Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature, J Clin Psychiatry, 70, 1078, 10.4088/JCP.08r04505 · DOI · Paper page
  21. Goncalves, 2010, The COX-2 inhibitors, meloxicam and nimesulide, suppress neurogenesis in the adult mouse brain, Br J Pharmacol, 159, 1118, 10.1111/j.1476-5381.2009.00618.x · DOI · Paper page
  22. Grösch, 2006, Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors, J Natl Cancer Inst, 98, 736, 10.1093/jnci/djj206 · DOI · Paper page
  23. Guo, 2012, Temperature dependence of protein folding kinetics in living cells, Proc Natl Acad Sci USA, 109, 17863, 10.1073/pnas.1201797109 · DOI · Paper page
  24. György, 2006, Citrullination: a posttranslational modification in health and disease, Int J Biochem Cell Biol, 38, 1662, 10.1016/j.biocel.2006.03.008 · DOI · Paper page
  25. Hecker, 2012, SuperTarget goes quantitative: update on drug-target interactions, Nucleic Acids Res, 40, D1113, 10.1093/nar/gkr912 · DOI · Paper page
  26. Hirsch, 2003, The role of glial reaction and inflammation in Parkinson’s disease, Ann N Y Acad Sci, 991, 214, 10.1111/j.1749-6632.2003.tb07478.x · DOI · Paper page
  27. Hong, 2005, SNAREs and traffic. Biochimica et Biophysica Acta (BBA)-, Mol Cell Res, 1744, 120
  28. Jafari, 2019, Why, when and how to adjust your P values?, Cell J, 20, 604
  29. Jafari, 2013, Exploring biological processes involved in embryonic stem cell differentiation by analyzing proteomic data, Biochim Biophys Acta, 1834, 1063, 10.1016/j.bbapap.2013.02.003 · doi:10.1016/j.bbapap.2013.02.003
  30. Jafari, 2014, The cellular thermal shift assay for evaluating drug target interactions in cells, Nat Protoc, 9, 2100, 10.1038/nprot.2014.138 · DOI · Paper page
  31. Jarzab, 2020, Meltome atlas-thermal proteome stability across the tree of life, Nat Methods, 17, 495, 10.1038/s41592-020-0801-4 · DOI · Paper page
  32. Johnson, 2002, The cyclo-oxygenase-2 inhibitor celecoxib perturbs intracellular calcium by inhibiting endoplasmic reticulum Ca2+-ATPases: a plausible link with its anti-tumour effect and cardiovascular risks, Biochem J, 366, 831, 10.1042/bj20020279 · DOI
  33. Jones, 2001, Nonsteroidal anti-inflammatory drug prescribing: past, present, and future, Am J Med, 110, 4S, 10.1016/S0002-9343(00)00627-6 · doi:10.1016/s0002-9343(00)00627-6
  34. Kang, 2009, Enhanced sensitivity of celecoxib in human glioblastoma cells: induction of DNA damage leading to p53-dependent G1 cell cycle arrest and autophagy, Mol Cancer, 8, 66, 10.1186/1476-4598-8-66 · DOI
  35. Kashfi, 2005, Non-COX-2 targets and cancer: expanding the molecular target repertoire of chemoprevention, Biochem Pharmacol, 70, 969, 10.1016/j.bcp.2005.05.004 · DOI
  36. Kim, 2007, GADD153 mediates celecoxib-induced apoptosis in cervical cancer cells, Carcinogenesis, 28, 223, 10.1093/carcin/bgl227 · doi:10.1093/carcin/bgl227
  37. Koehne, 2004, COX-2 inhibition and colorectal cancer, Semin Oncol, 31, 12, 10.1053/j.seminoncol.2004.03.041 · DOI · Paper page
  38. Kurganov, 2002, Kinetics of thermal aggregation of tobacco mosaic virus coat protein, Biochemistry (Mosc), 67, 525, 10.1023/A:1015589926728 · DOI
  39. Kutmon, 2016, WikiPathways: capturing the full diversity of pathway knowledge, Nucleic Acids Res, 44, D488, 10.1093/nar/gkv1024 · DOI · Paper page
  40. Kwiatkowska, 2017, Status of etoricoxib in the treatment of rheumatic diseases. Expert panel opinion, Reumatologia, 55, 290, 10.5114/reum.2017.72626 · DOI
  41. Lahusen, 2018, BRCA1 function in the intra-S checkpoint is activated by acetylation via a pCAF/SIRT1 axis, Oncogene, 37, 2343, 10.1038/s41388-018-0127-1 · DOI
  42. Larance, 2015, Multidimensional proteomics for cell biology, Nat Rev Mol Cell Biol, 16, 269, 10.1038/nrm3970 · DOI · Paper page
  43. Li, 2016, Label-free technologies for target identification and validation, MedChemComm, 7, 769, 10.1039/C6MD00045B · DOI
  44. Lomenick, 2011, Target identification using drug affinity responsive target stability (DARTS), Curr Protoc Chem Biol, 3, 163, 10.1002/9780470559277.ch110180 · DOI · Paper page
  45. Luo, 2015, The Rab2A GTPase promotes breast cancer stem cells and tumorigenesis via Erk signaling activation, Cell Rep, 11, 111, 10.1016/j.celrep.2015.03.002 · DOI
  46. Marnett, 1999, Arachidonic acid oxygenation by COX-1 and COX-2. Mechanisms of catalysis and inhibition, J Biol Chem, 274, 22903, 10.1074/jbc.274.33.22903 · DOI · Paper page
  47. Masferrer, 2000, Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors, Cancer Res, 60, 1306
  48. Mateus, 2017, Thermal proteome profiling: unbiased assessment of protein state through heat-induced stability changes, Proteome Sci, 15, 13, 10.1186/s12953-017-0122-4 · DOI · Paper page
  49. McGeer, 2004, Inflammation and neurodegeneration in Parkinson’s disease, Parkinsonism Relat Disord, 10, S3, 10.1016/j.parkreldis.2004.01.005 · DOI · Paper page
  50. Nam, 2015, Comparison of pharmacological and genetic inhibition of cyclooxygenase-2: effects on adult neurogenesis in the hippocampal dentate gyrus, J Vet Sci, 16, 245, 10.4142/jvs.2015.16.3.245 · DOI
  51. Nickchi, 2015, PEIMAN 1.0: post-translational modification enrichment, integration and matching ANalysis, Database (Oxford), 2015, 10.1093/database/bav037 · DOI
  52. Onder, 2004, NSAID-related psychiatric adverse events: who is at risk?, Drugs, 64, 2619, 10.2165/00003495-200464230-00001 · DOI
  53. Pace, 1980, Substrate stabilization of lysozyme to thermal and guanidine hydrochloride denaturation, J Biol Chem, 255, 3862, 10.1016/S0021-9258(19)85604-1 · DOI · Paper page
  54. Paulson, 2001, Pharmacokinetics of celecoxib after oral administration in dogs and humans: effect of food and site of absorption, J Pharmacol Exp Ther, 297, 638, 10.1016/S0022-3565(24)29580-X · DOI · Paper page
  55. Pei, 2007, Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer, J Proteome Res, 6, 2495, 10.1021/pr060644r · DOI
  56. Perazella, 2001, Selective cyclooxygenase-2 inhibitors: a pattern of nephrotoxicity similar to traditional nonsteroidal anti-inflammatory drugs, Am J Med, 111, 64, 10.1016/S0002-9343(01)00757-4 · DOI · Paper page
  57. Petsko GA, Ringe D (2004) Protein structure and function, New Science Press.
  58. Piran, 2020, Can we assume the gene expression profile as a proxy for signaling network activity?, Biomolecules, 10, 850, 10.3390/biom10060850 · DOI · Paper page
  59. Pyrko, 2007, Calcium-activated endoplasmic reticulum stress as a major component of tumor cell death induced by 2,5-dimethyl-celecoxib, a non-coxib analogue of celecoxib, Mol Cancer Ther, 6, 1262, 10.1158/1535-7163.MCT-06-0629 · DOI
  60. Rahme, 2007, Hospitalization for gastrointestinal bleeding associated with non-steroidal anti-inflammatory drugs among elderly patients using low-dose aspirin: a retrospective cohort study, Rheumatology (Oxford), 46, 265, 10.1093/rheumatology/kel223 · DOI
  61. Reckzeh, 2019, Target engagement of small molecules: thermal profiling approaches on different levels, Methods Mol Biol, 1888, 73, 10.1007/978-1-4939-8891-4_4 · DOI
  62. Reinhard, 2015, Thermal proteome profiling monitors ligand interactions with cellular membrane proteins, Nat Methods, 12, 1129, 10.1038/nmeth.3652 · DOI · Paper page
  63. Sams-Dodd, 2005, Target-based drug discovery: is something wrong?, Drug Discov Today, 10, 139, 10.1016/S1359-6446(04)03316-1 · DOI · Paper page
  64. Schenone, 2013, Target identification and mechanism of action in chemical biology and drug discovery, Nat Chem Biol, 9, 232, 10.1038/nchembio.1199 · DOI · Paper page
  65. Schmidt, 2010, GSK/Sirtris compounds dogged by assay artifacts, Nat Biotechnol, 28, 185, 10.1038/nbt0310-185 · DOI
  66. Schönthal, 2007, Direct non-cyclooxygenase-2 targets of celecoxib and their potential relevance for cancer therapy, Br J Cancer, 97, 1465, 10.1038/sj.bjc.6604049 · DOI · Paper page
  67. Scifo, 2015, Proteomic analysis of the palmitoyl protein thioesterase 1 interactome in SH-SY5Y human neuroblastoma cells, J Proteomics, 123, 42, 10.1016/j.jprot.2015.03.038 · DOI
  68. Skuta, 2017, Probes & Drugs portal: an interactive, open data resource for chemical biology, Nat Methods, 14, 759, 10.1038/nmeth.4365 · DOI
  69. Smith, 2000, Cyclooxygenases: structural, cellular, and molecular biology, Annu Rev Biochem, 69, 145, 10.1146/annurev.biochem.69.1.145 · DOI · Paper page
  70. Strickland, 2013, Thermodynamic analysis of protein-ligand binding interactions in complex biological mixtures using the stability of proteins from rates of oxidation, Nat Protoc, 8, 148, 10.1038/nprot.2012.146 · DOI
  71. Swinney, 2013, Phenotypic vs. target-based drug discovery for first-in-class medicines, Clin Pharmacol Ther, 93, 299, 10.1038/clpt.2012.236 · DOI · Paper page
  72. Tanaka, 2005, Involvement of intracellular Ca2+ levels in nonsteroidal anti-inflammatory drug-induced apoptosis, J Biol Chem, 280, 31059, 10.1074/jbc.M502956200 · DOI
  73. Tang, 2018, Drug target commons: a community effort to build a consensus knowledge base for drug-target interactions, Cell Chem Biol, 25, 224, 10.1016/j.chembiol.2017.11.009 · DOI · Paper page
  74. Tanoli, 2018, Drug Target Commons 2.0: a community platform for systematic analysis of drug-target interaction profiles, Database (Oxford), 2018, 1, 10.1093/database/bay083 · DOI · Paper page
  75. Terzi, 2018, The use of non-steroidal anti-inflammatory drugs in neurological diseases, J Chem Neuroanat, 87, 12, 10.1016/j.jchemneu.2017.03.003 · DOI
  76. Tzeng, 2016, Rab-mediated vesicle trafficking in cancer, J Biomed Sci, 23, 70, 10.1186/s12929-016-0287-7 · DOI · Paper page
  77. Ungermann, 2005, Functions of SNAREs in intracellular membrane fusion and lipid bilayer mixing, J Cell Sci, 118, 3819, 10.1242/jcs.02561 · DOI
  78. Usman, 2014, Heat shock proteins: functions and response against heat stress in plants, Int J Sci Technol Res, 3, 204
  79. Vedadi, 2006, Chemical screening methods to identify ligands that promote protein stability, protein crystallization, and structure determination, Proc Natl Acad Sci USA, 103, 15835, 10.1073/pnas.0605224103 · DOI · Paper page
  80. Wang, 2004, Effect of celecoxib on Ca2+ movement and cell proliferation in human osteoblasts, Biochem Pharmacol, 67, 1123, 10.1016/j.bcp.2003.11.004 · doi:10.1016/j.bcp.2003.11.004
  81. Wang, 2017, Celecoxib-induced inhibition of neurogenesis in fetal frontal cortex is attenuated by curcumin via Wnt/β-catenin pathway, Life Sci, 185, 95, 10.1016/j.lfs.2017.07.028 · DOI
  82. West, 2008, Thermodynamic analysis of protein stability and ligand binding using a chemical modification- and mass spectrometry-based strategy, Anal Chem, 80, 4175, 10.1021/ac702610a · DOI · Paper page
  83. West, 2010, Quantitative proteomics approach for identifying protein-drug interactions in complex mixtures using protein stability measurements, Proc Natl Acad Sci USA, 107, 9078, 10.1073/pnas.1000148107 · DOI · Paper page
  84. Wishart, 2018, DrugBank 5.0: a major update to the DrugBank database for 2018, Nucleic Acids Res, 46, D1074, 10.1093/nar/gkx1037 · DOI · Paper page
  85. Wiśniewski, 2009, Universal sample preparation method for proteome analysis, Nat Methods, 6, 359, 10.1038/nmeth.1322 · DOI · Paper page
  86. Wongrakpanich, 2018, A comprehensive review of non-steroidal anti-inflammatory drug use in the elderly, Aging Dis, 9, 143, 10.14336/AD.2017.0306 · DOI · Paper page
  87. Yaksh, 2001, The acute antihyperalgesic action of nonsteroidal, anti-inflammatory drugs and release of spinal prostaglandin E2 is mediated by the inhibition of constitutive spinal cyclooxygenase-2 (COX-2) but not COX-1, J Neurosci, 21, 5847, 10.1523/JNEUROSCI.21-16-05847.2001 · DOI · Paper page
  88. Zagidullin, 2019, DrugComb: an integrative cancer drug combination data portal, Nucleic Acids Res, 47, W43, 10.1093/nar/gkz337 · DOI · Paper page
  89. Zhao, 2007, Cellular functions of NSF: not just SNAPs and SNAREs, FEBS Lett, 581, 2140, 10.1016/j.febslet.2007.03.032 · DOI · Paper page
  90. Zhou, 2016, Lysine acetylation stabilizes SP2 protein in the silkworm Bombyx mori, J Insect Physiol, 91–92, 56, 10.1016/j.jinsphys.2016.06.008 · DOI

Cited by

See all 18

Metadata

Authors
Gholizadeh, E., Karbalaei, R., Khaleghian, A., Salimi, M., Gilany, K., Soliymani, R., Tanoli, Z., Rezadoost, H., Baumann, M., Jafari, M., & Tang, J.
Venue
Molecular Pharmacology
Publisher
Elsevier BV
Published
2021-05
Volume
99
Issue
5
Pages
308-318
ISSN
0026-895X
Cited by
18
References
12
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.